middle.news
How IMEXHS’s Mexico Tender Win and Cost Cuts Are Driving ARR Growth
1:03pm on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
How IMEXHS’s Mexico Tender Win and Cost Cuts Are Driving ARR Growth
1:03pm on Thursday 31st of July, 2025 AEST
Key Points
Q2 FY25 revenue stable at $6.6 million, slight 3% decline year-on-year
Annualised Recurring Revenue (ARR) up 11% to $32.8 million
Completed $2.6 million capital raising to fund growth initiatives
Won significant public tender at Mexico’s Neurológico de México adding $206,000 NARR
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imexhs (ASX:IME)
OPEN ARTICLE